InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the detailed record of transactions filed by Humphreys Keith, Director. Director active across 3 companies, notably Indivior Pharmaceuticals, Inc.. Aggregated, 3 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. History available since 5 January 2026. The latest transaction was disclosed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Humphreys Keith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
6,518 shares0Common StockSEC:0002014900-26-000009:0
3,722 shares0Common StockSEC:0002014900-26-000006:0
775 shares@ US$35.3926100.0% of flowOrdinary SharesSEC:0002014900-26-000004:0
Canonical exit: 5 Apr 2026 (T+90)
3 of 3 declarations
About Humphreys Keith
Keith Humphreys is a Director at Indivior Pharmaceuticals, Inc. He plays a key role in the governance of the company, bringing his expertise in pharmaceutical strategy. Keith is involved in making strategic decisions that influence product development and the direction of the company. His experience in the pharmaceutical sector is a valuable asset for Indivior.
